Sumitomo Pharma Co., Ltd.
4506.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥23,116,000 | ¥29,047,000 | ¥143,478,000 | ¥202,984,000 |
| Short-Term Investments | ¥16,840,000 | ¥7,085,000 | ¥0 | ¥0 |
| Receivables | ¥74,840,000 | ¥97,239,000 | ¥95,908,000 | ¥151,407,000 |
| Inventory | ¥94,222,000 | ¥115,350,000 | ¥94,405,000 | ¥99,021,000 |
| Other Curr. Assets | ¥44,150,000 | ¥37,064,000 | ¥48,069,000 | ¥46,109,000 |
| Total Curr. Assets | ¥253,168,000 | ¥269,569,000 | ¥381,860,000 | ¥499,521,000 |
| Property Plant & Equip (Net) | ¥46,648,000 | ¥57,895,000 | ¥58,909,000 | ¥64,091,000 |
| Goodwill | ¥197,406,000 | ¥199,783,000 | ¥209,415,000 | ¥195,144,000 |
| Intangibles | ¥172,509,000 | ¥195,652,000 | ¥329,314,000 | ¥398,692,000 |
| Long-Term Investments | ¥56,501,000 | ¥161,711,000 | ¥113,833,000 | ¥127,909,000 |
| Tax Assets | ¥534,000 | ¥0 | ¥10,845,000 | ¥22,650,000 |
| Other NC Assets | ¥15,838,000 | ¥22,896,000 | ¥30,566,000 | ¥0 |
| Total NC Assets | ¥489,436,000 | ¥637,937,000 | ¥752,882,000 | ¥808,486,000 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥742,604,000 | ¥907,506,000 | ¥1,134,742,000 | ¥1,308,007,000 |
| Liabilities | – | – | – | – |
| Payables | ¥38,544,000 | ¥67,720,000 | ¥13,403,000 | ¥22,455,000 |
| Short-Term Debt | ¥46,440,000 | ¥285,517,000 | ¥90,588,000 | ¥25,085,000 |
| Tax Payable | ¥1,577,000 | ¥1,348,000 | ¥24,053,000 | ¥7,583,000 |
| Deferred Revenue | ¥0 | ¥0 | ¥151,952,000 | ¥140,034,000 |
| Other Curr. Liab. | ¥154,042,000 | ¥158,456,000 | ¥239,990,000 | ¥201,642,000 |
| Total Curr. Liab. | ¥240,603,000 | ¥515,474,000 | ¥372,694,000 | ¥278,373,000 |
| LT Debt | ¥258,982,000 | ¥133,367,000 | ¥244,128,000 | ¥243,963,000 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥16,877,000 | ¥27,932,000 |
| Deferred Tax Liab, NC | ¥26,550,000 | ¥38,211,000 | ¥36,505,000 | ¥26,550,000 |
| Other NC Liab. | ¥41,520,000 | ¥59,119,000 | ¥50,760,000 | ¥47,587,000 |
| Total NC Liab. | ¥332,522,000 | ¥235,896,000 | ¥355,266,000 | ¥356,065,000 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥5,199,000 | ¥6,996,000 | ¥10,033,000 |
| Total Liabilities | ¥573,125,000 | ¥751,370,000 | ¥727,960,000 | ¥634,438,000 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥22,400,000 | ¥22,400,000 | ¥22,400,000 | ¥22,400,000 |
| Retained Earnings | ¥46,784,000 | -¥22,665,000 | ¥280,999,000 | ¥514,210,000 |
| AOCI | ¥100,977,000 | ¥157,010,000 | ¥104,032,000 | ¥55,234,000 |
| Other Equity | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥169,479,000 | ¥156,063,000 | ¥406,749,000 | ¥607,888,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥73,000 | ¥33,000 | ¥65,681,000 |
| Total Liab. & Tot. Equity | ¥742,604,000 | ¥907,506,000 | ¥1,134,742,000 | ¥1,308,007,000 |
| Net Debt | ¥282,306,000 | ¥389,837,000 | ¥191,238,000 | ¥66,064,000 |